Cryoport R&D Spending Growth & History (CYRX)
Cryoport's r&d spending was $17.0M for fiscal 2025.
View full Cryoport company overviewCryoport annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $17.0M | −$669,000 | −3.78% |
| 2024 | 2024-12-31 | $17.7M | −$330,000 | −1.83% |
| 2023 | 2023-12-31 | $18.0M | $2.3M | +14.74% |
| 2022 | 2022-12-31 | $15.7M | −$1.1M | −6.66% |
| 2021 | 2021-12-31 | $16.8M | $7.4M | +77.59% |
| 2020 | 2020-12-31 | $9.5M | $5.7M | +153.52% |
| 2019 | 2019-12-31 | $3.7M | $1.9M | +103.27% |
| 2018 | 2018-12-31 | $1.8M | $634,751 | +52.65% |
| 2017 | 2017-12-31 | $1.2M | $607,586 | +101.59% |
| 2016 · Dec 31 | 2016-12-31 | $598,106 | — | — |
| 2016 · Mar 31 | 2016-03-31 | $550,263 | $197,683 | +56.07% |
| 2015 | 2015-03-31 | $352,580 | −$56,531 | −13.82% |
| 2014 | 2014-03-31 | $409,111 | −$16,335 | −3.84% |
| 2013 | 2013-03-31 | $425,446 | −$66,403 | −13.50% |
| 2012 | 2012-03-31 | $491,849 | $42,720 | +9.51% |
| 2011 | 2011-03-31 | $449,129 | — | — |
Cryoport quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $4.9M | $734,000 | +17.82% |
| Q1 2026 | 2026-03-31 | $3.9M | −$27,000 | −0.69% |
| Q4 2025 | 2025-12-31 | $4.5M | $311,000 | +7.48% |
| Q3 2025 | 2025-09-30 | $4.5M | $366,000 | +8.80% |
| Q2 2025 | 2025-06-30 | $4.1M | −$528,000 | −11.36% |
| Q1 2025 | 2025-03-31 | $3.9M | −$818,000 | −17.21% |
| Q4 2024 | 2024-12-31 | $4.2M | −$594,000 | −12.51% |
| Q3 2024 | 2024-09-30 | $4.2M | −$995,000 | −19.31% |
| Q2 2024 | 2024-06-30 | $4.6M | $383,000 | +8.98% |
| Q1 2024 | 2024-03-31 | $4.8M | $876,000 | +22.60% |
| Q4 2023 | 2023-12-31 | $4.7M | $72,000 | +1.54% |
| Q3 2023 | 2023-09-30 | $5.2M | $1.2M | +29.28% |
| Q2 2023 | 2023-06-30 | $4.3M | $741,000 | +21.04% |
| Q1 2023 | 2023-03-31 | $3.9M | $338,000 | +9.55% |
| Q4 2022 | 2022-12-31 | $4.7M | $788,000 | +20.26% |
| Q3 2022 | 2022-09-30 | $4.0M | −$203,000 | −4.85% |
| Q2 2022 | 2022-06-30 | $3.5M | −$940,000 | −21.07% |
| Q1 2022 | 2022-03-31 | $3.5M | −$766,000 | −17.80% |
| Q4 2021 | 2021-12-31 | $3.9M | $397,000 | +11.37% |
| Q3 2021 | 2021-09-30 | $4.2M | $1.9M | +81.14% |
| Q2 2021 | 2021-06-30 | $4.5M | $2.5M | +129.17% |
| Q1 2021 | 2021-03-31 | $4.3M | $2.6M | +148.36% |
| Q4 2020 | 2020-12-31 | $3.5M | $2.4M | +226.37% |
| Q3 2020 | 2020-09-30 | $2.3M | $671,472 | +40.93% |
| Q2 2020 | 2020-06-30 | $1.9M | $1.4M | +259.93% |
| Q1 2020 | 2020-03-31 | $1.7M | $1.2M | +253.97% |
| Q4 2019 | 2019-12-31 | $1.1M | $471,182 | +78.69% |
| Q3 2019 | 2019-09-30 | $1.6M | $1.2M | +254.05% |
| Q2 2019 | 2019-06-30 | $540,933 | $92,342 | +20.58% |
| Q1 2019 | 2019-03-31 | $489,596 | $159,866 | +48.48% |
| Q4 2018 | 2018-12-31 | $598,761 | $218,446 | +57.44% |
| Q3 2018 | 2018-09-30 | $463,361 | $118,563 | +34.39% |
| Q2 2018 | 2018-06-30 | $448,591 | $217,855 | +94.42% |
| Q1 2018 | 2018-03-31 | $329,730 | $79,887 | +31.97% |
| Q4 2017 | 2017-12-31 | $380,315 | $277,166 | +268.70% |
| Q3 2017 | 2017-09-30 | $344,798 | $130,118 | +60.61% |
| Q2 2017 · Jun 30 | 2017-06-30 | $230,736 | $94,937 | +69.91% |
| Q1 2017 · Mar 31 | 2017-03-31 | $249,843 | $105,365 | +72.93% |
| Q4 2016 | 2016-12-31 | $103,149 | −$124,616 | −54.71% |
| Q2 2017 · Sep 30 | 2016-09-30 | $214,680 | $114,384 | +114.05% |
| Q1 2017 · Jun 30 | 2016-06-30 | $135,799 | $58,075 | +74.72% |
| Q4 2016 · Mar 31 | 2016-03-31 | $144,478 | $59,473 | +69.96% |
| Q3 2016 | 2015-12-31 | $227,765 | $128,713 | +129.94% |
| Q2 2016 | 2015-09-30 | $100,296 | $11,017 | +12.34% |
| Q1 2016 | 2015-06-30 | $77,724 | −$1,520 | −1.92% |
| Q4 2015 | 2015-03-31 | $85,005 | $5,463 | +6.87% |
| Q3 2015 | 2014-12-31 | $99,052 | −$19,438 | −16.40% |
| Q2 2015 | 2014-09-30 | $89,279 | −$29,157 | −24.62% |
| Q1 2015 | 2014-06-30 | $79,244 | −$13,399 | −14.46% |
| Q4 2014 | 2014-03-31 | $79,542 | −$40,458 | −33.72% |
| Q3 2014 | 2013-12-31 | $118,490 | $24,066 | +25.49% |
| Q2 2014 | 2013-09-30 | $118,436 | $16,780 | +16.51% |
| Q1 2014 | 2013-06-30 | $92,643 | −$16,309 | −14.97% |
| Q4 2013 | 2013-03-31 | $120,000 | −$25,000 | −17.24% |
| Q3 2013 | 2012-12-31 | $94,424 | −$26,576 | −21.96% |
| Q2 2013 | 2012-09-30 | $101,656 | −$23,344 | −18.68% |
| Q1 2013 | 2012-06-30 | $108,952 | $7,952 | +7.87% |
| Q4 2012 | 2012-03-31 | $145,000 | $37,526 | +34.92% |
| Q3 2012 | 2011-12-31 | $121,000 | $15,980 | +15.22% |
| Q2 2012 | 2011-09-30 | $125,000 | $10,486 | +9.16% |
| Q1 2012 | 2011-06-30 | $101,000 | −$21,121 | −17.30% |
| Q4 2011 | 2011-03-31 | $107,474 | — | — |
| Q3 2011 | 2010-12-31 | $105,020 | — | — |
| Q2 2011 | 2010-09-30 | $114,514 | — | — |
| Q1 2011 | 2010-06-30 | $122,121 | — | — |
Cryoport r&d spending trends
Over the last five fiscal years, Cryoport's r&d spending increased from $9.5M to $17.0M, a change of $7.6M. The latest reported quarter, Q2 2026, shows $4.9M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cryoport source filings ↗